Biocompatibility and launch profiles on the nanovehicle in vitro. (A) Cell viabilities of BMSCs treated by FSR NPs at a number of concentrations for 24h and 72h. 0. These effects delivered powerful proof the as-ready FSR nanoparticles possessed Excellent catalytic Homes for chemodynamic therapy i